FDA Homepage
Meeting: Administering the Hatch-Waxman Amendments
- Access directions for attending this July 18 public meeting in person or by webcast.
- Meeting: Administering the Hatch-Waxman Amendments
FDA takes steps under new Drug Competition Action Plan
- Lists off-patent drugs without approved generics, implements new policy to expedite application review.
- FDA takes steps under new Drug Competition Action Plan
Tattoo Removal: Options and Results
- How hard is it to remove a tattoo? What processes are used? Is it painful?
- Tattoo Removal: Options and Results
News & Events
- July 13, 2017 - Statement from FDA Commissioner Scott Gottlieb, M.D., on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse
- July 13, 2017 - Statement from Alberto Gutierrez, Ph.D., Director, Office of In Vitro Diagnostics and Radiological Health, FDA’s Center for Devices and Radiological Health on the status of FDA’s investigation into inaccurate results from certain lead tests
- July 07, 2017 - FDA approves new treatment for sickle cell disease
Newsroom
Recent Consumer Updates
Browse by Audience
-
For Consumers
Updates and information for staying safe and healthy -
For Patients
Learn about other treatments, drug/device approvals, public meetings and more -
For Health Professionals
Medical product safety information, adverse event/problem reporting and more -
For Scientists & Researchers
NCTR, pediatrics, clinical trials, Critical Path Initiative and more -
For Industry
Guidance, registration and listing, pay user fees, import programs and more
FDA Voice Blog
Page Last Updated: 07/14/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English